An Elegant Platform

By Nana Dadzie Ghansah

From A. KITTERMAN AND V. ALTOUNIAN/SCIENCE

Novavax’s COVID-19 vaccine — NVX-CoV2373 — ,ay be the last US-made vaccine to go for approval, but its platform might be the most elegant…if you ask me.

Unlike those on the market already, it is neither RNA nor DNA-based. It is a protein-based vaccine, and that protein is none other than the notorious spike protein of SARS-CoV-2.